Emerg Infect Dis. 2019 Jun;25(6):1050-1057. doi: 10.3201/eid2506.181755.
West Nile virus (WNV) and Usutu virus (USUV) circulate in several European Union (EU) countries. The risk of transfusion-transmitted West Nile virus (TT-WNV) has been recognized, and preventive blood safety measures have been implemented. We summarized the applied interventions in the EU countries and assessed the safety of the blood supply by compiling data on WNV positivity among blood donors and on reported TT-WNV cases. The paucity of reported TT-WNV infections and the screening results suggest that blood safety interventions are effective. However, limited circulation of WNV in the EU and presumed underrecognition or underreporting of TT-WNV cases contribute to the present situation. Because of cross-reactivity between genetically related flaviviruses in the automated nucleic acid test systems, USUV-positive blood donations are found during routine WNV screening. The clinical relevance of USUV infection in humans and the risk of USUV to blood safety are unknown.
西尼罗河病毒(WNV)和乌苏图病毒(USUV)在几个欧盟(EU)国家传播。已经认识到输血传播西尼罗河病毒(TT-WNV)的风险,并实施了预防血液安全措施。我们总结了欧盟国家应用的干预措施,并通过编译献血者中 WNV 阳性率和报告的 TT-WNV 病例数据来评估血液供应的安全性。报告的 TT-WNV 感染病例较少,以及对 TT-WNV 病例的认识或报告不足,表明血液安全干预措施是有效的。然而,WNV 在欧盟的有限传播以及对 TT-WNV 病例的假定漏报或漏报促成了目前的情况。由于在自动化核酸检测系统中与遗传上相关的黄病毒之间存在交叉反应性,因此在常规 WNV 筛查期间会发现 USUV 阳性的献血。USUV 感染对人类的临床相关性以及 USUV 对血液安全性的风险尚不清楚。